The effects of anastrozole on neonatal rat skin

European Journal of Gynaecological Oncology

Volumn 28, Issue 6, 2007, Pages 534-536

  Akcali, C ^a,b   Inaloz, S ^a   Karakok, M ^a   Demirtas, O C ^a   Kirtak, N ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Üniversite Bui 23   (Turkey)

Author keywords

Anastrazole; Rat; Skin

Indexed keywords

ANASTROZOLE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EPIDERMIS CELL; FEMALE; HISTOPATHOLOGY; HYPERTROPHY; KERATINIZATION; NONHUMAN; RAT;

ANIMALS; ANIMALS, NEWBORN; AROMATASE INHIBITORS; FEMALE; NITRILES; RATS; RATS, SPRAGUE-DAWLEY; SKIN; TRIAZOLES;

EID: 37749007394     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Inaloz H.S., Deveci E., Inaloz S.S., Unal B., Eralp A., Can I.: "The effects of tamoxifen on rat skin". Eur. J. Gynaecol. Oncol., 2002, 23, 50.
2. Dowsett M., Folkerd E., Doody D., Haynes B.: "The biology of steroid hormones and endocrine treatment of breast cancer". Breast., 2005, 14, 452.
3. Mouridsen H.T.: "Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women". Curr. Med. Res. Opin. 2006, 22, 1609.
4. Jonat W., Hilpert F., Kaufmann M.: "Aromatase inhibitors: a safety comparison". Expert Opin Drug Saf., 2007, 6, 165.
5. Sereda D., Werth V.P.: "Improvement in dermatomyositis rash associated with the use of antiestrogen medication". Arch. Dermatol. 2006, 142, 70.
6. Brueggemeier R.W., Hackett J.C., Diaz-Cruz E.S.: "Aromatase inhibitors in the treatment of breast cancer". Endocr. Rev., 2005, 26, 331.
7. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S. et al.: "Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis". Endocr. Rev. 1994, 15, 342.
8. Geisler J., King N., Dowsett M., Ottestad L., Lundgren S., Walton P. et al.: "Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatization and plasma oestrogen levels in postmenopausal women with breast cancer". Br. J. Cancer, 1996, 74, 1286.
9. Buzdar A., Jonat W., Howell A., Jones S.E., Blomqvist C., Vogel C.L. et al.: "Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group". J. Clin. Oncol., 1996, 14, 2000.
10. Bonneterre J., Buzdar A., Nabholtz J.M., Robertson J.F., Thurlimann B., von Euler M. et al.: "Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma". Cancer, 2001, 92, 2247.
11. Dewhurst L.O., Gee J.W., Rennie I.G., MacNeil S.: "Tamoxifen, 17 beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin". Br. J. Cancer, 1997, 75, 860.
12. Bezwoda W.R.: "The treatment of disseminated malignant melanoma with special reference to the role of interferons, vinca alkaloids and tamoxifen". Cancer Treat. Rev., 1997, 23, 17.
13. Moghadam B.K., Hersini S., Barker B.F.: "Autoimmune progesterone dermatitis and stomatitis". Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 1998, 85, 537.
14. Tonelli F., Valanzano R., Brandi M.L.: "Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: results of an in vitro study". Surgery, 1994, 115, 473.
15. Hu D., Hughes M.A., Cherry G.W.: "Topical tamoxifen - a potential therapeutic regime in treating excessive dermal scarring?". Br. J. Plast. Surg., 1998, 51, 462.
16. Venturini M, Del Mastro L.: "Safety of adjuvant aromatase inhibitor therapy". Cancer Treat Rev., 2006, 32, 548.
17. Mouridsen H.T.: "Incidence and management of side effects associated with aromatase inhibitorsin the adjuvant treatment of breast cancer in postmenopausal women". Curr. Med. Res. Opin., 2006, 22, 1609.
18. Mackey J., Gelmon K.: "Adjuvant aromatase inhibitors in breast cancer therapy: significance of musculoskeletal complications". Curr. Opin. Oncol., 2007, 19 (suppl.), S9.
19. Shoda H., Inokuma S., Yajima N., Tanaka Y., Setoguchi K.: "Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment". Ann. Rheum. Dis. 2005, 64, 651.
20. Conti-Beltraminelli M., Pagani O., Ballerini G., Richetti A., Graffeo R., Ruggeri M. et al.: "Henoch-Schonlein purpura (HSP) during treatment with anastrozole". Ann. Oncol., 2007, 18, 205.
21. Xiao X., Hong L., Sheng M.: "Promoting effect of estrogen on the proliferation of hemangioma vascular endothelial cells in vitro". J. Pediatr. Surg., 1999, 34, 1603.
22. Gagliardi A.R, Hennig B., Collins D.C.: "Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors". Anticancer Res., 1996, 16 (3A), 1101.